Compare · ACMR vs DHR
ACMR vs DHR
Side-by-side comparison of ACM Research Inc. (ACMR) and Danaher Corporation (DHR): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACMR operates in Technology, while DHR operates in Industrials - the two are in different parts of the market.
- DHR is the larger of the two at $151.82B, about 27.3x ACMR ($5.56B).
- DHR has been more active in the news (19 items in the past 4 weeks vs 7 for ACMR).
- DHR has more recent analyst coverage (25 ratings vs 19 for ACMR).
- Company
- ACM Research Inc.
- Danaher Corporation
- Price
- -
- -
- Market cap
- $5.56B
- $151.82B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2017
- News (4w)
- 7
- 19
- Recent ratings
- 19
- 25
ACM Research Inc.
ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers with fine feature sizes; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating. The company markets and sells its products under the Ultra C brand name through direct sales force and third-party representatives. ACM Research, Inc. was incorporated in 1998 and is headquartered in Fremont, California.
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Latest ACMR
- Officer Mckechnie Mark exercised 55,199 shares at a strike of $16.95 and sold $4,264,971 worth of shares (55,199 units at $77.27) as part of a pre-agreed trading plan (SEC Form 4)
- Director Dun Haiping exercised 5,000 shares at a strike of $5.60 and sold $405,670 worth of shares (5,000 units at $81.13) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 10-Q filed by ACM Research Inc.
- ACM Research Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- ACM Research Reports Second Quarter 2026 Results
- ACM Research Expands Ultra C Tahoe into a Wet Processing Platform
- ACM Research’s Ultra ECP ap-p Horizontal Panel Electroplating Tool Receives First Production Order and Evaluation Order from Customers
- ACM Research to Release Second Quarter 2026 Financial Results on August 7, 2026
- SEC Form 4 filed by Officer Wang David H
- AXT Announces Tracy Liu Appointed to AXT, Inc. Board of Directors
Latest DHR
- President & CEO Blair Rainer sold $12,736,095 worth of shares (58,255 units at $218.63) (SEC Form 4)
- Executive Vice President Riley Christopher Paul was granted 41,072 shares, increasing direct ownership by 201% to 61,472 units (SEC Form 4)
- SEC Form 4 filed by EVP & Chief Financial Officer Gugino Matthew E
- SEC Form 4 filed by SVP-Chief Legal Officer Leiken Jonathan
- SVP, Chief Science Officer Gutierrez-Ramos Jose-Carlos was granted 13,477 shares, increasing direct ownership by 71% to 32,495 units (SEC Form 4)
- SEC Form 4 filed by Executive Vice President Sawyer Montgomery Julie A
- SEC Form 4 filed by VP, Chief Accounting Officer Bouda Christopher
- Executive Vice President Milosevich Gregory M was granted 15,402 shares, increasing direct ownership by 170% to 24,467 units (SEC Form 4)
- Chairman of Exec. Committee Rales Mitchell P was granted 500,000 shares, increasing direct ownership by 939% to 553,228 units (SEC Form 4)
- Chairman Rales Steven M was granted 500,000 shares, increasing direct ownership by 16% to 3,605,808 units (SEC Form 4)